Impact Biomedical (IBO) Total Non-Current Liabilities (2022 - 2023)
Impact Biomedical (IBO) reported Total Non-Current Liabilities of $15.5 million for Q3 2023.
Powered by 
Analysis
Impact Biomedical (IBO) Total Non-Current Liabilities (2022 - 2023) Analysis & Trends
At the end of FY2022, Impact Biomedical posted Total Non-Current Liabilities of $13.83 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Impact Biomedical | 409.72 Mn | 412.92 Mn | 2,000.00 | - |
API Access
Impact Biomedical Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();